SCHEMBL19974510

SCHEMBL19974510

O=C(O)[C@@H]1C[C@@H](O)CN1F

nearest known ligand 0.53

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.53
GAA P10253 1/20 0.33
MME P08473 1/20 0.32
ACE P12821 2/20 0.31
SCN9A Q15858 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13101906 1.00 ATM (0.53) ATMGAAMMEACESCN9A
SCHEMBL30438193 1.00 ATM (0.53) ATMGAAMMEACESCN9A
SCHEMBL28311654 1.00 ATM (0.53) ATMGAAMMEACESCN9A
SCHEMBL28210183 0.80 ATM (0.42) ATMGAA
SCHEMBL27925973 0.77 ATM (0.35) ATM
SCHEMBL28153658 0.76 ATM (0.57) ATMGAAMMEACE
SCHEMBL27678902 0.74 ATM (0.55) ATMGAAMMEACESCN9A
SCHEMBL6678799 0.73 ATM (0.53) ATMGAAMMEACE
SCHEMBL6819415 0.73 ATM (0.53) ATMGAAMMEACESCN9A
SCHEMBL1249542 0.73 ATM (0.70) ATMGAAMMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129125-A1 MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2025-04-24 US claimed
US-12187816-B2 Macrocyclic compounds and methods of use thereof GENENTECH, INC. (US) 2025-01-07 US claimed
EP-4168121-A2 MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Genentech, Inc. (US) 2023-04-26 EP claimed
CN-115702026-A Macrocyclic compounds and methods of use thereof 基因泰克公司 2023-02-14 CN claimed
US-20220106361-A1 MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2022-04-07 US claimed
US-20250129125-A1 MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF GENENTECH, INC. (US) 2025-04-24 US disclosed
US-12187816-B2 Macrocyclic compounds and methods of use thereof GENENTECH, INC. (US) 2025-01-07 US disclosed
EP-4168121-A2 MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Genentech, Inc. (US) 2023-04-26 EP disclosed
CN-109952299-B Fluorohydroxyproline derivatives for the preparation of protein degradation targeting chimeras 邓迪大学 2023-04-18 CN disclosed
CN-109952299-B Fluorohydroxyproline derivatives for the preparation of protein degradation targeting chimeras 邓迪大学 2023-04-18 CN disclosed
CN-115702026-A Macrocyclic compounds and methods of use thereof 基因泰克公司 2023-02-14 CN disclosed
CN-109678852-B 6-oxo-hexahydropyrimidine derivative, preparation method and pharmaceutical application thereof 南京中医药大学 2022-04-19 CN disclosed
US-20190255066-A1 FLUOROHYDROXYPROLINE DERIVATIVES USEFUL IN THE PREPARATION OF PROTEOLYSIS TARGETED CHIMERAS UNIVERSITY OF DUNDEE (GB) 2019-08-22 US disclosed
EP-3512844-A1 FLUOROHYDROXYPROLINE DERIVATIVES USEFUL IN THE PREPARATION OF PROTEOLYSIS TARGETED CHIMERAS University Of Dundee (GB) 2019-07-24 EP disclosed
EP-3512844-A1 FLUOROHYDROXYPROLINE DERIVATIVES USEFUL IN THE PREPARATION OF PROTEOLYSIS TARGETED CHIMERAS University Of Dundee (GB) 2019-07-24 EP disclosed
CN-109952299-A Fluorohydroxyproline derivatives for preparing protein degradation targeting chimeras 邓迪大学 2019-06-28 CN disclosed
CN-109952299-A Fluorohydroxyproline derivatives for preparing protein degradation targeting chimeras 邓迪大学 2019-06-28 CN disclosed
CN-109952299-A Fluorohydroxyproline derivatives for preparing protein degradation targeting chimeras 邓迪大学 2019-06-28 CN disclosed
WO-2018051107-A1 FLUOROHYDROXYPROLINE DERIVATIVES USEFUL IN THE PREPARATION OF PROTEOLYSIS TARGETED CHIMERAS UNIVERSITY OF DUNDEE (GB) 2018-03-22 WO disclosed
WO-2018051107-A1 FLUOROHYDROXYPROLINE DERIVATIVES USEFUL IN THE PREPARATION OF PROTEOLYSIS TARGETED CHIMERAS UNIVERSITY OF DUNDEE (GB) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220106361-A1 MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF PAICS, CYCS, LSS ATM 2729/4885GAA 1370/4885MME 1796/4885
US-12187816-B2 Macrocyclic compounds and methods of use thereof PAICS, CYCS, LSS ATM 2729/4885GAA 1370/4885MME 1796/4885
US-20250129125-A1 MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF PAICS, CYCS, LSS ATM 2729/4885GAA 1370/4885MME 1796/4885
US-20190255066-A1 FLUOROHYDROXYPROLINE DERIVATIVES USEFUL IN THE PREPARATION OF PROTEOLYSIS TARGETED CHIMERAS RNF114, CUL1, MDM2 ATM 4350/4885GAA 2255/4885MME 587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.